Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Receivables (2016 - 2025)

Merit Medical Systems' Receivables history spans 16 years, with the latest figure at $221.5 million for Q4 2025.

  • For Q4 2025, Receivables rose 7.08% year-over-year to $221.5 million; the TTM value through Dec 2025 reached $221.5 million, up 7.08%, while the annual FY2025 figure was $221.5 million, 7.08% up from the prior year.
  • Receivables for Q4 2025 was $221.5 million at Merit Medical Systems, down from $229.4 million in the prior quarter.
  • Across five years, Receivables topped out at $229.4 million in Q3 2025 and bottomed at $159.0 million in Q1 2021.
  • The 5-year median for Receivables is $184.2 million (2023), against an average of $187.7 million.
  • The largest annual shift saw Receivables decreased 0.17% in 2021 before it grew 13.17% in 2025.
  • A 5-year view of Receivables shows it stood at $170.1 million in 2021, then increased by 4.47% to $177.7 million in 2022, then increased by 6.04% to $188.4 million in 2023, then grew by 9.78% to $206.8 million in 2024, then grew by 7.08% to $221.5 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Receivables are $221.5 million (Q4 2025), $229.4 million (Q3 2025), and $218.5 million (Q2 2025).